Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

Pet Therapeutic Diet Corporate Growth and Development Strategy

Date : 13 April 2026

Latest Updates of Companies in the Pet Therapeutic Diet Market

Pet Therapeutic Diet Market Companies are Diamond Pet Foods, Farmina Pet Foods, Rayne Clinical Nutrition, Veterinary Nutrition Group

Your complete Pet Therapeutic Diet Market control center is just one click away - Downlaod for Free.

Company Headquarters Latest Update
JustFoodForDogs United States In March 2026, JustFoodForDogs, an industry pioneer in fresh, human-grade pet nutrition, launched the pet food industry's first comprehensive line of fresh, science-backed recipes intended to address four of the most common canine health challenges.
Diamond Pet Foods United States US-driven Diamond Pet Foods will recently supply its mid-range brand, Diamond Naturals dry dog and cat food, to the UK's rapidly developing natural pet food category.
Farmina Pet Foods United States In July 2025, Farmina Pet Foods entered into a national distribution agreement with MWI Animal Health, a veterinary supply organization. The collaboration makes Farmina's VetLife therapeutic diet line available to veterinary practices.
Rayne Clinical Nutrition United States In April 2025, Rayne Nutrition proudly announced the relaunch of its Skin Relief Dry Dog Food, a veterinary-exclusive, complete food diet designed to support dogs with atopic dermatitis, osteoarthritis, and different dermatologic conditions.
Veterinary Nutrition Group Australia This organization focuses on microbiome science, targeted nutrition, and fresh food preparations.

Recent Developments in the Pet Therapeutic Diet Market

  • In September 2025, Virbac, a French veterinary pharmaceutical laboratory, announced the European launch of Vikaly, the global first medicated food for cats. This breakthrough innovation creates a novel therapeutic strategy for companion animals, facilitating administration and enhancing treatment follow-up.
  • In September 2025, Lantheus Holdings, Inc. and GE HealthCare announced a high-class licensing agreement for GE HealthCare to advance production and commercialize Lantheus’ piflufolastat F18 in Japan for prostate cancer diagnostics and companion diagnostic use.

Supply Chain Analysis

R&D:

  • The research and development (R&D) process for pet therapeutic diet includes conceptualization and disease target identification, formulation and ingredient selection, prototyping and palatability trials, safety and efficacy validation, and regulatory compliance and finalization
  • Key Players: Virbac and Farmina Pet Foods

Manufacturing Processes:

  • The manufacturing processes for pet therapeutic diets involve highly measured, specialized steps intended to produce nutritionally precise, digestible, and often hypoallergenic food.
  • Key Players: Nestlé Purina PetCare and General Mills Inc. 

Patient Services:

  • Patient services involved in pet therapeutic diets are inclusive, veterinary-based programs intended to manage chronic diseases, help with recovery, or address specific health conditions via specialized nutrition.
  • Key Players: Hill's Pet Nutrition and Mars Petcare

Market Trends

The global pet therapeutic diet market size was estimated at USD 28.64 billion in 2025 and is predicted to increase from USD 30.91 billion in 2026 to approximately USD 61.38 billion by 2035, expanding at a CAGR of 7.92% from 2026 to 2035. The pet therapeutic diet market is growing because of the increasing prevalence of pet chronic diseases it caused by lifestyle factors like overfeeding, lack of exercise, and exposure to household pollutants, directly related to these situations.

Pet Therapeutic Diet Market Size is USD 30.91 Billion in 2026.

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales